HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javier Martin Selected Research

Interferons

6/202247XXY and 47XXX in Scleroderma and Myositis.
11/2019Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.
1/2019Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases.
4/2012Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study.
7/2007Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javier Martin Research Topics

Disease

32Rheumatoid Arthritis
01/2021 - 02/2006
17Poliomyelitis (Polio)
06/2022 - 05/2003
17Autoimmune Diseases (Autoimmune Disease)
06/2022 - 07/2005
16Systemic Scleroderma (Systemic Sclerosis)
06/2022 - 08/2010
13Inflammation (Inflammations)
01/2020 - 09/2005
12Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2022 - 02/2008
11Giant Cell Arteritis (Horton Disease)
03/2021 - 08/2005
9Infections
09/2021 - 05/2004
7Neoplasms (Cancer)
12/2018 - 08/2007
7Atherosclerosis
08/2011 - 02/2006
4Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 05/2007
4Cardiovascular Diseases (Cardiovascular Disease)
07/2019 - 08/2008
4Sarcoma (Soft Tissue Sarcoma)
12/2012 - 10/2005
3Vasculitis (Vasculitides)
03/2021 - 09/2009
3Agranulocytosis (Granulocytopenia)
10/2020 - 01/2016
3Hypersensitivity (Allergy)
01/2019 - 01/2015
3Ankylosing Spondylitis
05/2015 - 07/2013
3Rheumatic Diseases (Rheumatism)
04/2012 - 01/2008
3Purpura
01/2010 - 06/2005
2acute flaccid myelitis
06/2022 - 12/2007
2Schizophrenia (Dementia Praecox)
10/2019 - 01/2016
2Crohn Disease (Crohn's Disease)
10/2019 - 01/2016
2Hypoxia (Hypoxemia)
01/2019 - 12/2012
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2018 - 01/2016
2Psoriatic Arthritis
01/2016 - 12/2009
2Arthritis (Polyarthritis)
05/2015 - 04/2012
2Lupus Nephritis
11/2013 - 04/2009
2Dentin Sensitivity
02/2013 - 03/2011
1Klinefelter Syndrome (Klinefelter's Syndrome)
06/2022
1Myositis (Idiopathic Inflammatory Myopathies)
06/2022
1Yellow Fever
01/2022
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1Drug-Related Side Effects and Adverse Reactions
10/2020
1Neutropenia
10/2020
1Calcinosis
10/2020
1Necrosis
11/2019
1Mixed Connective Tissue Disease (MCTD)
01/2019
1Fibrosis (Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

18VaccinesIBA
06/2022 - 05/2004
13Biomarkers (Surrogate Marker)IBA
07/2019 - 09/2005
9AutoantibodiesIBA
01/2021 - 02/2008
8Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2012
8CytokinesIBA
11/2019 - 12/2006
7HLA-B Antigens (HLA-B)IBA
03/2021 - 07/2013
7HLA-DRB1 Chains (HLA DRB1)IBA
01/2021 - 02/2007
7AntibodiesIBA
03/2015 - 04/2009
5InterferonsIBA
06/2022 - 07/2007
4Interleukin-18 (Interleukin 18)IBA
03/2016 - 01/2010
4AntigensIBA
05/2012 - 09/2009
3Protein Tyrosine PhosphatasesIBA
11/2018 - 07/2005
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2018 - 04/2014
3Pharmaceutical PreparationsIBA
01/2016 - 02/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2015 - 02/2006
3Peptides (Polypeptides)IBA
03/2015 - 12/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2009
3C-Reactive ProteinIBA
02/2009 - 02/2007
2Prednisone (Sone)FDA LinkGeneric
07/2019 - 12/2007
2Tumor Necrosis Factor InhibitorsIBA
01/2019 - 01/2018
2Deoxyribonucleases (DNase)FDA Link
01/2019 - 11/2016
2Transcription Factors (Transcription Factor)IBA
01/2018 - 01/2010
2P-2 (P 2)IBA
10/2017 - 03/2016
2Infliximab (Remicade)FDA Link
03/2015 - 04/2011
2Immunoglobulin G (IgG)IBA
03/2015 - 09/2009
2Biological ProductsIBA
02/2014 - 01/2013
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2013 - 12/2011
2Interleukin-10 (Interleukin 10)IBA
01/2013 - 07/2007
2EpitopesIBA
01/2012 - 08/2008
2Acid PhosphataseIBA
01/2012 - 07/2011
2Macrophage Migration-Inhibitory FactorsIBA
11/2011 - 04/2010
2Genetic Markers (Genetic Marker)IBA
07/2011 - 02/2011
2IgG Receptors (Fc gamma RI)IBA
08/2010 - 01/2006
2Toll-Like Receptor 4IBA
01/2010 - 07/2009
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2005 - 06/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2005 - 06/2005
1Complement System Proteins (Complement)IBA
06/2022
1WastewaterIBA
09/2021
1HLA-DRB1*04:01 antigenIBA
03/2021
1Intergenic DNA (Junk DNA)IBA
01/2021
1cyclic citrullinated peptideIBA
01/2021
1Immunomodulating AgentsIBA
01/2021
1Viral VaccinesIBA
11/2020
1EnzymesIBA
11/2020
1RNA Polymerase IIIIBA
11/2020
1Analgesics (Analgesic Drugs)IBA
10/2020
1Dipyrone (Metamizole)IBA
10/2020
1Viral RNAIBA
10/2020
1Fibroblast Growth Factor-23IBA
10/2020
1Unithiol (DMPS)IBA
01/2020
1A-Form DNA (A-DNA)IBA
11/2019
1Endothelin-1 (Endothelin 1)IBA
07/2019
1PlasticsIBA
01/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2019
1RibonucleoproteinsIBA
01/2019
1Transcription Factor 3IBA
01/2019
1ChromatinIBA
01/2019
1A-factor (Streptomyces)IBA
12/2018
1histone H3 trimethyl Lys4IBA
10/2018

Therapy/Procedure

4Therapeutics
04/2011 - 02/2006
3Drug Therapy (Chemotherapy)
01/2016 - 01/2012
2Immunotherapy
01/2018 - 01/2015